GB Sciences Statistics
Total Valuation
GB Sciences has a market cap or net worth of 40,707. The enterprise value is 2.03 million.
Market Cap | 40,707 |
Enterprise Value | 2.03M |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GB Sciences has 407.07 million shares outstanding. The number of shares has increased by 4.24% in one year.
Current Share Class | 407.07M |
Shares Outstanding | 407.07M |
Shares Change (YoY) | +4.24% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.67% |
Owned by Institutions (%) | n/a |
Float | 400.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.42 |
PB Ratio | -0.01 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.93 |
EV / Sales | 20.90 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.36 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -438.99% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 15.94% |
Revenue Per Employee | 48,618 |
Profits Per Employee | -527,753 |
Employee Count | 2 |
Asset Turnover | 0.80 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.81% in the last 52 weeks. The beta is 9.86, so GB Sciences's price volatility has been higher than the market average.
Beta (5Y) | 9.86 |
52-Week Price Change | -92.81% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 43.76 |
Average Volume (20 Days) | 32,147 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, GB Sciences had revenue of 97,235 and -1.06 million in losses. Loss per share was -0.00.
Revenue | 97,235 |
Gross Profit | 97,235 |
Operating Income | -848,406 |
Pretax Income | -1.04M |
Net Income | -1.06M |
EBITDA | -847,938 |
EBIT | -848,406 |
Loss Per Share | -0.00 |
Balance Sheet
The company has 3,016 in cash and 1.99 million in debt, giving a net cash position of -1.99 million or -0.00 per share.
Cash & Cash Equivalents | 3,016 |
Total Debt | 1.99M |
Net Cash | -1.99M |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -5.88M |
Book Value Per Share | -0.01 |
Working Capital | -5.32M |
Cash Flow
Operating Cash Flow | -506,443 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -872.53% |
Pretax Margin | -1,072.60% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GB Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.24% |
Shareholder Yield | n/a |
Earnings Yield | -2,592.93% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GB Sciences has an Altman Z-Score of -1735.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1735.7 |
Piotroski F-Score | 1 |